Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-23-040269

Director sold 585 shares at $46.76 ($27,355)

From the SEC's structured data for this filing

Trades in this filing

Sanders Corazon (Corsee) D. · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-06-30 Sale : show line 1 in the form −585 $46.76 $27,355 8,985 D
Open-market sales · 585 sh · avg $46.76 · $27,355
Loading xslF345X04/doc4.xml…